TC
RNAM

Truvestments Capital’s Avidity Biosciences RNAM Stock Holding History

Truvestments Capital’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$721 – 1210
2025
Q4 		$721 Hold
10
– – ﹤0.01% 938
2025
Q3 		$436 Hold
10
– – ﹤0.01% 976
2025
Q2 		$284 Hold
10
– – ﹤0.01% 917
2025
Q1 		$295 Hold
10
– – ﹤0.01% 979
2024
Q4 		$291 Hold
10
– – ﹤0.01% 971
2024
Q3 		$459 Buy
+10
New +$434 ﹤0.01% 876

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Truvestments Capital's RNAM Position: Q1 2026 in Review

Truvestments Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 10 shares — an estimated $721 sold.

Truvestments Capital first reported a position in RNAM in Q3 2024 and held it in 6 quarters. The position peaked at $721 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Truvestments Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Truvestments Capital sold 10 Avidity Biosciences shares in Q1 2026, an estimated $721.
  • Truvestments Capital first reported a position in Avidity Biosciences in Q3 2024 and held it in 6 quarters.
  • Truvestments Capital's Avidity Biosciences position peaked at $721 in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.